SkinMedica Launches Redness Relief CalmPlexâ„¢
CARLSBAD, Calif., Feb. 3, 2011 /PRNewswire/ -- SkinMedica, Inc., the fastest-growing professional skin care company in the United States, today announced that it is introducing a new, fast-acting anti-redness product, Redness Relief CalmPlex™—the biggest innovation in redness in over two decades. It is the first and only non-prescription product clinically proven to reduce visible redness.
This revolutionary formula contains, CalmPlex™, a patented, nature-inspired ingredient that treats the underlying causes of redness by inhibiting the release of a key natural vasodilator as well as niacinamide which helps to strengthen the skin by supporting the barrier function.
"Visible redness is a real and emotional burden for millions of people," commented SkinMedica Founder, Richard Fitzpatrick, MD. "As dermatologists, we have been frustrated by the lack of effective approaches to reducing the appearance of redness. Backed by solid science and clinical results, Redness Relief CalmPlex™ represents a truly novel advance in the skin aesthetics area."
Ideal for sensitive skin types, this non-comedogenic formula contains no added fragrance and offers relief and results to improve overall skin appearance by neutralizing unwanted redness.
In multiple clinical studies, Redness Relief CalmPlex™ demonstrated efficacy in relieving visible redness and improving overall skin tone. SkinMedica Redness Relief CalmPlex™ demonstrated a 40% reduction in UV-induced redness in as early as 3 days. Redness Relief CalmPlex™ also provided significant reductions in chronic redness after 1 week with continued improvement through week twelve.